Sonoma Pharmaceuticals, Inc. (SNOA) financial statements (2020 and earlier)

Company profile

Business Address 1129 N. MCDOWELL BLVD.
PETALUMA, CA 94954
State of Incorp. DE
Fiscal Year End March 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments441017765
Cash and cash equivalents441017765
Receivables5322222
Inventory, net of allowances, customer advances and progress billings3332211
Inventory3332211
Prepaid expense 211111
Other undisclosed current assets20100  
Total current assets:14121623131010
Noncurrent Assets
Operating lease, right-of-use asset1
Property, plant and equipment0111111
Long-term investments and receivables     510
Long-term investments     510
Other noncurrent assets0000000
Other undisclosed noncurrent assets1111   
Total noncurrent assets:32331511
TOTAL ASSETS:16141925141521
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2333322
Accounts payable2111111
Accrued liabilities 111100
Employee-related liabilities 111111
Taxes payable   0   
Deferred revenue0
Debt0000000
Derivative instruments and hedges, liabilities     03
Deferred revenue and credits 0113
Other liabilities 0     
Other undisclosed current liabilities1000   
Total current liabilities:4433438
Noncurrent Liabilities
Long-term debt and lease obligation1000  0
Long-term debt, excluding current maturities 000  0
Capital lease obligations 00   
Operating lease, liability1
Liabilities, other than long-term debt0  1001
Deferred revenue and credits 1001
Deferred revenue0
Other undisclosed noncurrent liabilities 00    
Total noncurrent liabilities:1011001
Total liabilities:5444439
Stockholders' equity
Stockholders' equity attributable to parent11101521101212
Common stock0000000
Additional paid in capital186184177169166158149
Accumulated other comprehensive loss(4)(4)(4)(4)(4)(4)(3)
Accumulated deficit(171)(169)(157)(143)(152)(142)(134)
Total stockholders' equity:11101521101212
TOTAL LIABILITIES AND EQUITY:16141925141521

Income statement (P&L) ($ in millions)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
Revenues19191713151414
Revenue, net 13151426
Cost of revenue(10)(10)(9)(7)(8)(7)(5)
Cost of goods and services sold(8)(0)(0)(7)(8)(7)(5)
Gross profit:9976778
Operating expenses(15)(20)(21)(19)(17)(14)(14)
Operating loss:(7)(11)(14)(13)(10)(7)(6)
Nonoperating income (expense)0000(0)(5)11
Investment income, nonoperating00000(5)11
Other nonoperating expense(0)   (0)(0)(0)
Interest and debt expense(0)(0)(0)(0)(0)(0)(1)
Income (loss) from continuing operations before equity method investments, income taxes:(7)(11)(14)(13)(10)(11)4
Other undisclosed income (loss) from continuing operations before income taxes(0)(0)(0)0   
Income (loss) from continuing operations before income taxes:(7)(11)(14)(13)(10)(11)4
Income tax expense (benefit) (0) 4 3(0)
Other undisclosed loss from continuing operations(0)      
Income (loss) from continuing operations:(7)(12)(14)(9)(10)(9)4
Income from discontinued operations   18   
Net income (loss):(7)(12)(14)9(10)(9)4
Other undisclosed net income attributable to parent3   010
Net income (loss) available to common stockholders, diluted:(5)(12)(14)9(10)(8)4

Comprehensive Income ($ in millions)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
Net income (loss):(7)(12)(14)9(10)(9)4
Other comprehensive income (loss) (12)(14)9(11)  
Other undisclosed comprehensive loss(12)      
Comprehensive income (loss):(19)(24)(28)18(21)(9)4
Other undisclosed comprehensive income, net of tax, attributable to parent3    00
Comprehensive income (loss), net of tax, attributable to parent:(16)(24)(28)18(21)(9)4

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: